Are you scheduled for surgery due to Cervical Spondylotic Myelopathy?


15763

Efficacy of Riluzole in Patients with Cervical Spondylotic Myelopathy Undergoing Surgical Treatment

Neurological Surgery

Shaffrey Chris,

UVa Health System, Department of Neurological Surgery seeks adults ages 18 and 75 years for a research study. If you have Cervical Spondylotic Myelopathy and are scheduled to undergo surgical treatment for this condition, you may qualify for this study. The purpose of the study is to see if an experimental drug called Riluzole will aid in the protection of the spinal cord compared to placebo (fake pill). Riluzole is a drug that has been shown to prevent cell death in trauma cases, nerve injury and in some disease that cause the nerves to degenerate. However it is not approved by the FDA for use in those with Cervical Soondylotic Myelopathy. The study involves: • taking the study medication Riluzole or placebo • blood draws • x rays; • 8 clinic study visits over about 1 year will be required. Each visit will occur at the same time as your standard treatment visits, and add about 1-2 hours to procedures you are already having as part of your clinical care. Study- medication is provided free of charge. No compensation is provided for this study. If you are interested or want more information please contact: • Amy Halpin • 434-243-7226 or abh3b@virginia.edu • IIRB-HSR # 15763 Principal Investigator: Christopher I. Shaffrey, MD


Adult

Neck/Back/Spinal Surgery

Neurosurgery

Ill

No Compensation

Amy Halpin

abh3b@Virginia.EDU

4342437336